Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares are displaying elevated levels of volatility in today’s session. After a recent check, shares have been spotted at $18.57 showing a change in the session of 4.97%.Based on data provided from analysts, Aimmune Therapeutics, Inc. has a current consensus target price of 36.80. The current consensus analyst recommendation is sitting at 1.60 on company shares. Investors will likely be tracking any consensus estimate changes heading into the next earnings period.
Moving Averages and ATR
After a recent spot-check, Aimmune Therapeutics, Inc. (NASDAQ:AIMT)’s ATR is 0.84. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-days) of the True Range. The range of a day’s trading is high-low, and True Range expands into yesterday’s close when it lands outside of today’s range.
Taking a closer look into the volatility on shares of Aimmune Therapeutics, Inc. (NASDAQ:AIMT), we notice that the stock is 5.43% off of the 20-Day Simple Moving Average. Zooming out to the 50-Day Simple Moving Average, we can see a difference of -0.84% from current stock levels.
Going out even further, the 200-Day Simple Moving Average is recorded -4.95% away from the current share price. Company shares were recently noted -10.16% off of the 50-day high and 16.28% away from the 50-day low. Let’s also take a quick peek at the 52 week highs/lows. At present, the stock is -32.00% separated from the 52 week high and 90.07% from the low.